Homepage
Author:
Harbour Biomed
Posted Date:
June 11, 2026
Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor
Harbour Biomed
June 11, 2026
Harbour BioMed Appoints Dr. Luisa Salter-Cid as Scientific Advisor
Harbour Biomed
June 10, 2026
Harbour BioMed Announces NMPA Acceptance of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors
Harbour Biomed
June 10, 2026
First Patients Dosed in Phase 2 SIRIUS COPD Study of HBM9378/WIN378, a Fully Human Ultra Long-Acting Anti-TSLP Antibody
Harbour Biomed
June 9, 2026
Harbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate
Harbour Biomed
May 17, 2026
Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors
Harbour Biomed
May 8, 2026
Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Advance Global Scientific Strategy and Innovation
Harbour Biomed
May 6, 2026
Nona Biosciences Evolves Brand to Reflect Next Phase of Growth in Biotherapeutic Innovation
Harbour Biomed
May 5, 2026
Harbour BioMed Appoints Dr. Adam Zong as President
Harbour Biomed
April 16, 2026
Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth
Harbour Biomed
March 30, 2026
1
2
Next
